Research
Molecular
PPARγ inhibition reverses ALOXE3-mediated insulin sensitization.
Inhibiting PPARγ may counteract the benefits of ALOXE3 in insulin sensitivity.
StrongSupportsmedium confidence
Strikingly, PPARγ inhibition reversed hepatic ALOXE3-mediated insulin sensitization.
Why this rating
The study provides clear evidence of the interaction through experimental results.
Source
ALOXE3 is a hepatic fasting-responsive lipoxygenase that enhances insulin sensitivity via hepatic PPARγ
Cassandra B. Higgins et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2018
other
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →